Receptor Recovery Did Not Immediately Restore a Cannabinoid Pain Response in Mice
In a mouse brain-injection experiment, surface CB1 receptor recovery preceded recovery of the antinociceptive response. Receptor abundance and functional sensitivity did not follow the same timetable.
A specialized exposure route
Investigators administered experimental cannabinoid agonists directly into brain ventricles and assessed supraspinal antinociception, receptor-related measurements and morphine cross-tolerance. The design isolated central mechanisms rather than reproducing smoked or swallowed THC.
A downstream mechanism remained plausible
A single exposure produced prolonged functional tolerance under these conditions. Surface receptors returned earlier, and reducing Gz signaling disrupted the persistent desensitization and cross-tolerance. The results supported post-receptor contributions rather than explaining the entire response through continuing receptor loss.
No human recovery clock follows
Brain injection, experimental agonists and mouse nociception cannot determine how long a person’s cannabis tolerance or impairment lasts. The study also does not establish that ordinary cannabis use produces the same prolonged response after one dose. Its useful distinction is mechanistic: a receptor-count measurement alone may be insufficient to infer restored function. Exposure, receptor signaling, behavior and recovery require their own evidence.
Related analysis: Cannabis Tolerance Claims: Questions to Ask Before Relying on Expert Testimony.
Primary research
Gz mediates the long-lasting desensitization of brain CB1 receptors and is essential for cross-tolerance with morphine. Molecular pain (2009). DOI: 10.1186/1744-8069-5-11.
